Alivion AG
Personalized weight management by breath biomarkers
Alivion, an ETH Spin-off, develops handheld devices to detect biomarkers in breath to define individual fat-burns rate for personalized weight management. Target market: weight management monitoring for diets (incl. GLP-1), fitness & sports, longevity enhusiasts (market potential > $70bn; double digit growth). Business model (B2B; non-medical): Phase 1: Sales of handheld devices 'Nutrion' through distributor to dieticians & endocrinologists and App subscription for gameification and recommendations (and advertisment income from Freemium App); Phase 2: Sales of 'Neo' device and App Subscription for B2B2C (non-medical) for sports and longevity enhusisasts.
Only registered users have access to funding information.
Please log in or register to continue. Registration is free.
24.01.2025
Alivion: The Venture Leader Mobile developing handheld devices for personalized weight management (venturelab.swiss)
23.01.2025
Venturelab starts 2025 internationally with the Venture Leaders Mobile kick-off (venturelab.swiss)
05.05.2025
Several CLAs signed for 3rd financing round covering >20% of financial round
05.05.2025
Prof. Dr. Felix Beuschlein (Clinic Director USZ Endocrinology) & Dr. Willy Bischofberger (Lealy Founder) join Advisory Board
05.05.2025
Partnership negotiations with international analytical instrumentation company in place
02.04.2025
37 pre-launch-orders of Nutrion, Core App and Insights Browswer Software
02.04.2025
No Jobs
Videos
Nutrion Solution
Venture Leaders Mobile
The Venture Leaders - as members of the Swiss National Startup Team - have a clear-cut goal. They envision themselves as global players and want to take the first step to their global expansion. The Venture Leaders’ startup development program is specifically structured to help them achieve these goals. Each year, the Venture Leaders Mobile journey offers selected entrepreneurs an accelerated learning curve and a solid network through their participation at the Mobile World Congress and 4YFN Conference.
Alivion AG
Personalized weight management by breath biomarkers
Website:
alivion.ch/de/home
Headquarter:
Glattbrugg
Foundation Date:
October 2020
Technology:
- Medtech
Sectors:
- Digital Health
Support received
